© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The latest drugs approved by the Food and Drug Administration include one for non-small-cell lung cancer and acute myeloid leukemia.
Poorer outcomes for Black and Hispanic patients significantly depend on where they live.
The drug targets cancer’s survival proteins, making them more vulnerable to treatments that cause cancer cells to self-destruct.
Some patients develop a secondary blood cancer after receiving radiation or chemotherapy treatment for their initial cancer diagnosis
Scientists studied how a series of stepwise mutations in normal blood cells could trigger the transformation to cancer.
The regimen is approved for adults age 75 or older and those who cannot use intensive induction chemotherapy.
Brown, formerly known as “the Berlin Patient,” died at his home surrounded by his partner and friends.
The trial will test the drug acalabrutinib in those with acute myeloid leukemia, acute lymphoblastic leukemia and myelodysplastic syndromes.
Here are latest arrivals approved by the Food and Drug Administration.
The new drug improved overall survival for people who could not complete curative chemotherapy.
Here’s a list of approved drugs to treat leukemia including acute lymphocytic or lymphoblastic leukemia (ALL), chronic lymphocytic le...
To find a better FTO-targeting drug, researchers searched a collection of 260,000 chemicals housed by NCI.
Author Suleika Jaouad’s new project helps people channel isolation into creativity and connection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.